BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21147213)

  • 61. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice.
    Carrier Y; Yuan J; Kuchroo VK; Weiner HL
    J Immunol; 2007 Jan; 178(1):179-85. PubMed ID: 17182553
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid.
    Lu L; Zhou X; Wang J; Zheng SG; Horwitz DA
    PLoS One; 2010 Dec; 5(12):e15150. PubMed ID: 21179414
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
    Young KJ; DuTemple B; Phillips MJ; Zhang L
    J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.
    Rossetti M; Spreafico R; Saidin S; Chua C; Moshref M; Leong JY; Tan YK; Thumboo J; van Loosdregt J; Albani S
    J Immunol; 2015 Jan; 194(1):113-24. PubMed ID: 25452562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
    Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
    Front Immunol; 2021; 12():686530. PubMed ID: 34777330
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cutting Edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells.
    Davidson TS; DiPaolo RJ; Andersson J; Shevach EM
    J Immunol; 2007 Apr; 178(7):4022-6. PubMed ID: 17371955
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
    Brehm MA; Kenney LL; Wiles MV; Low BE; Tisch RM; Burzenski L; Mueller C; Greiner DL; Shultz LD
    FASEB J; 2019 Mar; 33(3):3137-3151. PubMed ID: 30383447
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Infusion of ex-vivo expanded human TCR-αβ
    Achita P; Dervovic D; Ly D; Lee JB; Haug T; Joe B; Hirano N; Zhang L
    Clin Exp Immunol; 2018 Sep; 193(3):386-399. PubMed ID: 30066399
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: a role for bone marrow stromal cells in neutralizing regulatory T cells.
    Guichelaar T; Emmelot ME; Rozemuller H; Martini B; Groen RW; Storm G; Lokhorst HM; Martens AC; Mutis T
    Clin Cancer Res; 2013 Mar; 19(6):1467-75. PubMed ID: 23382115
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells.
    Wang C; Yi T; Qin L; Maldonado RA; von Andrian UH; Kulkarni S; Tellides G; Pober JS
    J Clin Invest; 2013 Apr; 123(4):1677-93. PubMed ID: 23478407
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells.
    Fiori A; Uhlig S; Klüter H; Bieback K
    Cells; 2021 Jan; 10(1):. PubMed ID: 33401501
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.
    Sthoeger ZM; Sharabi A; Dayan M; Zinger H; Asher I; Sela U; Mozes E
    Hum Immunol; 2009 Mar; 70(3):139-45. PubMed ID: 19280712
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.
    Foley JE; Jung U; Miera A; Borenstein T; Mariotti J; Eckhaus M; Bierer BE; Fowler DH
    J Immunol; 2005 Nov; 175(9):5732-43. PubMed ID: 16237064
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
    Taams LS; Smith J; Rustin MH; Salmon M; Poulter LW; Akbar AN
    Eur J Immunol; 2001 Apr; 31(4):1122-31. PubMed ID: 11298337
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta.
    Selvaraj RK; Geiger TL
    J Immunol; 2007 Jul; 179(2):11 p following 1390. PubMed ID: 17695668
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans.
    Fanigliulo D; Lazzerini PE; Capecchi PL; Ulivieri C; Baldari CT; Laghi-Pasini F
    Int Immunopharmacol; 2015 Feb; 24(2):276-284. PubMed ID: 25536542
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human LAP
    Wang H; Song H; Pham AV; Cooper LJ; Schulze JJ; Olek S; Tran DQ
    Theranostics; 2019; 9(8):2315-2324. PubMed ID: 31149046
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
    Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
    J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
    Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE
    Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.